Stay updated on SAGE-217 in Parkinson's Disease: Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 in Parkinson's Disease: Clinical Trial page.

Latest updates to the SAGE-217 in Parkinson's Disease: Clinical Trial page
- Check4 days agoChange DetectedMinor layout/visual adjustments observed on the Study Details page; core trial information appears unchanged — to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior version tag v3.1.0 was removed.SummaryDifference0.7%

- Check33 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision tag updated from v3.0.1 to v3.0.2; the 'Back to Top' element has been removed.SummaryDifference0.0%

- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.0%

- Check62 days agoChange DetectedThe web page has been updated to include new drug information for Zuranolone and Tyrosine, along with a revised facility name and location details, while removing several previous drug-related topics and location specifics.SummaryDifference0.8%

Stay in the know with updates to SAGE-217 in Parkinson's Disease: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 in Parkinson's Disease: Clinical Trial page.